Endodontic Medications for Irreversible Pulpitis: Articaine or Eugenol?

University Hospital, Strasbourg, France100 enrolled

Overview

The objective of the study is to determine which of the two commonly used endodontic medications (Eugenol VS Articaine) is most effective in controlling postoperative pain in irreversible pulpitis of the mature permanent tooth in adults. To do so, an assessment of the pain felt by patients will be carried out a few days apart. The supposed results are that the medications are equivalent in terms of effectiveness on the pain, but could then present different economic arguments

In irreversible pulpitis of the mature permanent tooth, the enrolled patients receive endodontic medications (Eugenol or Articaine) in order to determine which one is the more efficient to control the pain. These patients would have received the same medication without this study. That's why this is an obsevationnal study.

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Pulpitides Endodontic Inflammation Toothaches Operative Dentistry

Interventions

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Adult patient, major, affiliated to a social health insurance scheme * Patient having agreed to participate in the study * Urgent consultant patient for irreversible pulpitis * Patient understanding French Exclusion Criteria: * Refusal of the patient to participate in the study * Impossibility of performing the surgical procedure * Impossibility to give the subject information enlightened (difficulty of understanding ...) * Subject under the protection of justice, or under guardianship * General contraindication to endodontic treatment in 2 sessions (high risk of infectious endocarditis, for example) * Chronic intake of analgesic drugs

Outcomes

Primary Outcomes

Pain evolution (decrease or increase the intensity of the pain)

Evolution of pain (using a score of 0 to 10)

Time frame: 7 days